ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

RETRACTED: Marine-Derived Piericidin Diglycoside S18 Alleviates Inflammatory Responses in the Aortic Valve via Interaction with Interleukin 37 (Retracted Article)

Li, Shunyi; She, Jianglian; Zeng, Jingxin; Xie, Kaiji; Luo, Zichao; Su, Shuwen; Chen, Jun; Xian, Gaopeng; Cheng, Zhendong; Zhao, Jing; Li, Shaoping; Xu, Xingbo; Xu, Dingli*; Tang, Lan*; Zhou, Xuefeng*; Zeng, Qingchun*南方医科大学; 中国科学院
Oxidative Medicine and Cellular Longevity2022-8-17DOI: 10.1155/2022/6776050
1被引8阅读
引用收藏
分享

摘要

Calcific aortic valve disease (CAVD) is a valvular disease frequently in the elderly individuals that can lead to the valve dysfunction. Osteoblastic differentiation of human aortic valve interstitial cells (HAVICs) induced by inflammation play a crucial role in CAVD pathophysiological processes. To date, no effective drugs for CAVD have been established, and new agents are urgently needed. Piericidin glycosides, obtained from a marine-derived Streptomyces strain, were revealed to have regulatory effects on mitochondria in previous studies. Here, we discovered that 13-hydroxypiericidin A 10-O-alpha-D-glucose (1 -> 6)-beta-D-glucoside (S18), a specific piericidin diglycoside, suppresses lipopolysaccharide- (LPS) induced inflammatory responses of HAVICs by alleviating mitochondrial stress in an interleukin (IL)-37-dependent manner. Knockdown of IL-37 by siRNA not only exaggerated LPS-induced HAVIC inflammation and mitochondrial stress but also abrogated the anti-inflammatory effect of S18 on HAVICs. Moreover, S18 alleviated aortic valve lesions in IL-37 transgenic mice of CAVD model. Microscale thermophoresis (MST) and docking analysis of five piericidin analogues suggested that diglycosides, but not monoglycosides, exert obvious IL-37-binding activity. These results indicate that S18 directly binds to IL-37 to alleviate inflammatory responses in HAVICs and aortic valve lesions in mice. Piericidin diglycoside S18 is a potential therapeutic agent to prevent the development of CAVD.

学科与关键词

关键词
INTERSTITIAL-CELLSEXPRESSIONSUPPRESSESDISEASECALCIFICATIONDYSFUNCTIONMECHANISMSMODELSDAMAGEIL-37
相关
加载中…
  • Targeted inhibition of PTPN22 is a novel approach to alleviate osteogenic responses in aortic valve interstitial cells and aortic valve lesions in mice
    Li, Shunyi; Luo, Zichao; Su, Shuwen; Wen, Liming; Xian, Gaopeng; Zhao, Jing; Xu, Xingbo; Xu, Dingli*; Zeng, Qingchun*BMC Medicine, 2023, 21(1): 252.被引 1
  • Hesperetin, a Promising Dietary Supplement for Preventing the Development of Calcific Aortic Valve Disease
    Zhao, Hengli; Xian, Gaopeng; Zeng, Jingxin; Zhong, Guoheng; An, Dongqi; Peng, You; Hu, Dongtu; Lin, Yingwen; Li, Juncong; Su, Shuwen; Ning, Yunshan; Xu, Dingli*; Zeng, Qingchun*Antioxidants, 2022, 11(11): 2093.被引 4
  • 4-Octyl itaconate suppresses the osteogenic response in aortic valvular interstitial cells via the Nrf2 pathway and alleviates aortic stenosis in mice with direct wire injury
    Peng, Xin; Su, Shuwen; Zeng, Jingxin; Xie, Kaiji; Yang, Xi; Xian, Gaopeng; Xiao, Zezhou; Zhu, Peng; Zheng, Shaoyi*; Xu, Dingli*; Zeng, Qingchun*Free Radical Biology and Medicine, 2022, 188: 404-418.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Oxidative Medicine and Cellular Longevity
发表日期
2022-08-17
卷期
第 2022 卷
页码
6776050
DOI
10.1155/2022/6776050
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Science and Technology Program of Guangzhou; Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory; Youth Science and Technology Innovation Talent Program of Guangdong TeZhi Plan; Guangdong Local Innovation Team Program; [81770386]; [82070403]; [81973388]; [81973235]; [201804010086]; [2021A0505030031]; [2018GZR110105001]; [2019TQ05Y136]; [2019BT02Y262]

作者

  • L

    Li, Shunyi (第一作者)

    southern med univ

  • S

    She, Jianglian

    new · southern med univ · cas · chinese acad sci

查看全部 16 位作者收起作者
  • Z

    Zeng, Jingxin

    southern med univ

  • X

    Xie, Kaiji

    southern med univ

  • L

    Luo, Zichao

    southern med univ

  • S

    Su, Shuwen

    southern med univ

  • C

    Chen, Jun

    southern med univ

  • X

    Xian, Gaopeng

    southern med univ

  • C

    Cheng, Zhendong

    southern med univ

  • Z

    Zhao, Jing

  • L

    Li, Shaoping

  • X

    Xu, Xingbo

  • X

    Xu, Dingli (通讯)

    southern med univ

  • T

    Tang, Lan (通讯)

    new · southern med univ

  • Z

    Zhou, Xuefeng (通讯)

    cas · chinese acad sci

  • Z

    Zeng, Qingchun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417